POET Technologies Surges on Lumilens Pact as Class Action and Production Timeline Collide

POET shares surge 26% on Lumilens partnership for optical interconnects; class-action lawsuit and manufacturing challenges loom as company aims to commercialize EOI platform.

POET Technologies shares rocketed as much as 26% on Thursday, touching an intraday high of $20.65 after the company unveiled a partnership with venture-backed startup Lumilens for next-generation optical interconnects. The rally pushed the stock’s year-to-date gain past 330%, but the euphoria is colliding with a class-action lawsuit, a shareholder vote on a corporate relocation, and the daunting challenge of scaling a wafer-level manufacturing operation from scratch.

The collaboration centers on an Electrical-Optical Interposer (EOI) platform designed to eliminate the costly, manual active alignment required in conventional optical chip assembly. By shifting production to automated wafer-level fabrication, the partners aim to slash costs and boost throughput for high-speed transceivers targeting 800G and 1.6T data rates. Lumilens, backed by Mayfield and other venture capitalists, has placed an initial order worth $50 million, with the potential to grow to $500 million over five years. In return, Lumilens receives warrants to purchase nearly 23 million POET shares at an exercise price of $8.25; roughly one-tenth of those warrants are immediately exercisable, while the remainder vests upon hitting future revenue milestones.

The timeline for the first deliverables is aggressive. Engineering samples are slated for late 2026, with volume production expected by the following year. To prepare for that ramp, Chief Operating Officer Dr. Sandeep Kumar is building out manufacturing capacity in Malaysia, a key piece of POET’s shift from a pure concept developer into a commercial fabricator.

Yet the operational progress is shadowed by legal trouble that dates back to April, when Marvell Semiconductor terminated a contract, accusing POET of breaching confidentiality agreements and prematurely disclosing shipping information. The stock cratered 47% on the news. That incident, along with allegations that management misrepresented the company’s U.S. tax status, has spawned a securities fraud class action. Investors have until June 29 to file lead-plaintiff papers, just three days after a June 26 shareholder meeting where they will vote on a proposal to reincorporate POET in the United States, a move aimed at rebuilding trust with American institutional investors.

The stock’s extreme swings have been amplified by the arrival of the Defiance Daily Target 2X Long POET ETF, a leveraged product that gives speculative traders a double-dose of the already volatile shares. Between the deal momentum and the legal overhang, POET’s near-term trajectory will hinge on whether the company can turn its EOI prototype into a revenue-generating product while navigating a packed calendar of legal and corporate milestones.